Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of individual protein regions provides novel insights on cancer pharmacogenomics.

PLoS computational biology - 1 Jan 2015

Porta Pardo Eduard, Godzik Adam

Abstract excerpt

The promise of personalized cancer medicine cannot be fulfilled until we gain better understanding of the connections between the genomic makeup of a patient's tumor and its response to anticancer drugs. Several datasets that include both pharmacologic profiles of cancer cell lines as well as their genomic alterations have been recently developed and extensively analyzed. However, most analyses of these datasets...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Databases, Genetic
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Share to Protein Interaction Maps

Share to Protein Structure, Tertiary

Share to Proteins

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 25568936
DOI: 10.1371/journal.pcbi.1004024
PMCID: PMC4287345

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of individual protein regions provides novel insights on cancer pharmacogenomics.PMID 25568936Read ↗

Association analysis of the perturbation of interactions in biological pathways and anticancer drug activity.Semantic proximity Read ↗

Methods and resources to access mutation-dependent effects on cancer drug treatment.Semantic proximity Read ↗

A Landscape of Pharmacogenomic Interactions in Cancer.Semantic proximity Read ↗

Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.Semantic proximity Read ↗

Large-Scale Profiling of Kinase Dependencies in Cancer Cell Lines.Semantic proximity Read ↗

Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers.Semantic proximity Read ↗

Quantitative Structure-Mutation-Activity Relationship Tests (QSMART) model for protein kinase inhibitor response prediction.Semantic proximity Read ↗

Large-scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell LinesSemantic proximity Read ↗

Integrative Statistical Inferences for Drug Sensitivity Biomarkers in CancerSemantic proximity Read ↗

Systematic analysis of genotype-specific drug responses in cancer.Semantic proximity Read ↗

Tissue-Specific Signaling Networks Rewired by Major Somatic Mutations in Human Cancer Revealed by Proteome-Wide Discovery.Semantic proximity Read ↗

Genetic Interactions and Tissue Specificity Modulate the Association of Mutations with Drug Response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.